ABTI OTC
Alterola Biotech, Inc.
1W: +0.0%
1M: +0.0%
3M: -96.1%
YTD: -96.1%
1Y: +0.0%
3Y: -99.0%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
$0
+0.0% ▲
Operating Income
-$2M
+70.7% ▲
Net Income
-$2M
+76.2% ▲
EPS (Diluted)
$-0.00
+77.4% ▲
EBITDA
-$2M
+73.8% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 | $0 |
| Gross Margin | — | — | — | — | — |
| R&D Expenses | $0 | $0 | $0 | $2M | $46K |
| SG&A Expenses | $123K | $258K | $330K | $4M | $2M |
| Operating Expenses | $123K | $258K | $330K | $6M | $2M |
| Operating Income | -$123K | -$258K | -$330K | -$6M | -$2M |
| Operating Margin | — | — | — | — | — |
| Interest Expense | $11K | $249 | $0 | $0 | $0 |
| Income Before Tax | -$133K | -$259K | -$251K | -$6M | -$2M |
| Tax Expense | $0 | $0 | -$79K | $0 | -$155K |
| Net Income | -$133K | -$259K | -$172K | -$6M | -$2M |
| Net Margin | — | — | — | — | — |
| EPS (Diluted) | $-0.00 | $-0.00 | $-0.00 | $-0.01 | $-0.00 |
| EBITDA | -$123K | -$258K | -$251K | -$6M | -$2M |
| Shares Outstanding | 116M | 117M | 118M | 770M | 806M |